
This study evaluates the influence of facility case‐volume on nasopharyngeal carcinoma (NPC) treatments and overall survival (OS). The 2004–2015 National Cancer Database was queried for patients with NPC receiving definitive treatment. A total of 8260 patients (5‐year OS: 63.4%) were included. The 1114 unique facilities were categorized into 854 low‐volume (treating 1–8 patients), 200 intermediate‐volume (treating 9–23 patients), and 60 high‐volume (treating 24–187 patients) facilities...
Like
Save
Share